Apex Therapeutics, Inc.

Indianapolis, IN 46204

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $465K
First Award Date 09/30/09
Most Recent Award Date 07/01/13

Key Personnel

Last Name Name Awards Contact
Haslanger Martin F Haslanger 2
Kelley Mark R. Kelley 2
Qiao Xiaoxi Qiao 1

2 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 07/01/13 - 06/30/14

DESCRIPTION (provided by applicant): Our long-term goal is to develop a novel therapeutic strategy for childhood acute lymphoblastic leukemia (ALL), with focus on relapsed T-cell leukemia. We intend to accomplish this by targeting a unique molecular master regulator using a new generation of compounds. ALL is the most frequent cancer of the chil...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-08-051
Budget: 09/30/09 - 06/29/11

DESCRIPTION (provided by applicant): Age-related macular degeneration (AMD) is the leading cause of severe vision loss in people over age 60 and an estimated 8 million older-age Americans are at high risk to develop advanced AMD. Among two types of AMD, neovascular (wet) and non-neovascular (dry), neovascular AMD causes 90% of the vision loss. T...